Correlation Between Predictive Oncology and CeCors

Can any of the company-specific risk be diversified away by investing in both Predictive Oncology and CeCors at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Predictive Oncology and CeCors into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Predictive Oncology and CeCors Inc, you can compare the effects of market volatilities on Predictive Oncology and CeCors and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Predictive Oncology with a short position of CeCors. Check out your portfolio center. Please also check ongoing floating volatility patterns of Predictive Oncology and CeCors.

Diversification Opportunities for Predictive Oncology and CeCors

0.49

Correlation Coefficient

Predictive Oncology  CeCors

Very weak diversification

The 3 months correlation between Predictive and CeCors is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Predictive Oncology and CeCors Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CeCors Inc and Predictive Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Predictive Oncology are associated (or correlated) with CeCors. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CeCors Inc has no effect on the direction of Predictive Oncology i.e., Predictive Oncology and CeCors go up and down completely randomly.

Pair Corralation between Predictive Oncology and CeCors

Given the investment horizon of 90 days Predictive Oncology is expected to under-perform the CeCors. But the stock apears to be less risky and, when comparing its historical volatility, Predictive Oncology is 2.25 times less risky than CeCors. The stock trades about -0.01 of its potential returns per unit of risk. The CeCors Inc is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  2.56  in CeCors Inc on September 13, 2024 and sell it today you would earn a total of  0.33  from holding CeCors Inc or generate 12.89% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Predictive Oncology  vs.  CeCors Inc

Predictive Oncology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Predictive Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Predictive Oncology is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.

CeCors Inc

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in CeCors Inc are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, CeCors unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Predictive Oncology and CeCors

The main advantage of trading using opposite Predictive Oncology and CeCors positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Predictive Oncology position performs unexpectedly, CeCors can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CeCors will offset losses from the drop in CeCors' long position.

The idea behind Predictive Oncology and CeCors Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..